SK Biopharmaceuticals. (326030.KQ) Q1 2025 Earnings

6FebConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-33.1
750.46
1,534.01
2,317.56

Details

Expected EPS
191.9912493177
Actual EPS
2317.5648388656
Surprise EPS
2,125.57
Surprise Percent
+1,107.12%

Description

SK Biopharmaceuticals. (326030.KQ) has reported earnings of 2317.5648388656 per share for Q1 2025.

0 Comments

Share your thoughts